Tegaserod maleate
CAS: 189188-57-6
Ref. TM-T1551
10mg | 46,00 € | ||
25mg | 78,00 € | ||
50mg | 118,00 € | ||
100mg | 194,00 € | ||
200mg | 295,00 € | ||
500mg | 497,00 € | ||
1ml*10 (DMSO) | 50,00 € |
Información del producto
- HTF-919, SDZ-HTF-919
- (2E)-2-[(5-methoxy-1H-indol-3-yl)methylidene]-N-pentylhydrazinecarboximidamide (2Z)-but-2-enedioate (1:1)
- 2-[(5-Methoxy-1H-Indole-3-Yl)Methylene]-N-Pentylcarbazimidamide Hydrogen Maleate
- 2-[(Z)-(5-methoxy-3H-indol-3-ylidene)methyl]-N'-pentylhydrazinecarboximidamide (2Z)-but-2-enedioate
- Htf 919
- Hydrazinecarboximidamide, 2-[(5-methoxy-1H-indol-3-yl)methylene]-N-pentyl-, (2Z)-2-butenedioate (1:1)
- Hydrazinecarboximidamide, 2-[(5-methoxy-1H-indol-3-yl)methylene]-N-pentyl-, (Z)-2-butenedioate (1:1)
- Sdz-Htf 919
- Tegaserod Maleate
- Tegaserod hydrogen maleate
- Ver más sinónimos
- Tegaserode
- Tegibs 6
- Zelmac
- Zelnorm
Tegaserod maleate (SDZ-HTF-919) is a 5-HT4 agonist manufactured by Novartis and used for the management of irritable bowel syndrome and constipation. Its use was the only drug approved by the United States Food and Drug Administration to help relieve the abdominal discomfort, bloating and constipation associated with irritable bowel syndrome. On March 30, 2007, the U.S. Food and Drug Administration requested that Novartis withdraw Zelnorm from shelves. The FDA alleges a relationship between prescriptions of the drug and increased risks of heart attack or stroke.
Propiedades químicas
Consulta técnica sobre: TM-T1551 Tegaserod maleate
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.